The Importance of Diversity and Inclusion in Drug Development and Clinical Trial Conduct
Crossref DOI link: https://doi.org/10.1002/jcph.2151
Published Online: 2022-09-29
Published Print: 2022-12
Update policy: https://doi.org/10.1002/crossmark_policy
Moore, Kenneth T. https://orcid.org/0000-0001-7505-102X
Grundmann, Oliver https://orcid.org/0000-0003-2302-8949
Iwuchukwu, Otito
Rakhmanina, Natella
,
Version of Record valid from 2022-09-29
Publication History
Received: 2022-08-31
Accepted: 2022-09-03
Published: 2022-09-29
